Stifel Financial’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.48M | Sell |
19,597
-601
| -3% | -$135K | ﹤0.01% | 1410 |
|
|
2025
Q4 | $4.31M | Sell |
20,198
-176
| -0.9% | -$36.3K | ﹤0.01% | 1419 |
|
|
2025
Q3 | $4.05M | Buy |
20,374
+404
| +2% | +$75.4K | ﹤0.01% | 1417 |
|
|
2025
Q2 | $3.45M | Buy |
19,970
+3,874
| +24% | +$631K | ﹤0.01% | 1466 |
|
|
2025
Q1 | $2.51M | Sell |
16,096
-1,001
| -6% | -$143K | ﹤0.01% | 1605 |
|
|
2024
Q4 | $2.35M | Buy |
17,097
+4,534
| +36% | +$596K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $1.88M | Sell |
12,563
-544
| -4% | -$73.5K | ﹤0.01% | 1819 |
|
|
2024
Q2 | $1.79M | Sell |
13,107
-53
| -0.4% | -$7.21K | ﹤0.01% | 1794 |
|
|
2024
Q1 | $1.99M | Buy |
13,160
+579
| +5% | +$82.6K | ﹤0.01% | 1721 |
|
|
2023
Q4 | $1.58M | Sell |
12,581
-12
| -0.1% | -$1.2K | ﹤0.01% | 1828 |
|
|
2023
Q3 | $1.18M | Buy |
12,593
+2,941
| +30% | +$275K | ﹤0.01% | 1935 |
|
|
2023
Q2 | $861K | Buy |
9,652
+484
| +5% | +$42.1K | ﹤0.01% | 2174 |
|
|
2023
Q1 | $983K | Sell |
9,168
-205
| -2% | -$23.5K | ﹤0.01% | 2074 |
|
|
2022
Q4 | $1.14M | Buy |
9,373
+586
| +7% | +$68K | ﹤0.01% | 1896 |
|
|
2022
Q3 | $907K | Buy |
8,787
+497
| +6% | +$47.1K | ﹤0.01% | 2039 |
|
|
2022
Q2 | $771K | Buy |
8,290
+12
| +0.1% | +$1.13K | ﹤0.01% | 2185 |
|
|
2022
Q1 | $972K | Sell |
8,278
-165
| -2% | -$19.1K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $1.14M | Buy |
8,443
+954
| +13% | +$142K | ﹤0.01% | 2035 |
|
|
2021
Q3 | $1.19M | Buy |
7,489
+962
| +15% | +$132K | ﹤0.01% | 1949 |
|
|
2021
Q2 | $859K | Sell |
6,527
-89
| -1% | -$11.9K | ﹤0.01% | 2214 |
|
|
2021
Q1 | $853K | Sell |
6,616
-42
| -0.6% | -$6.38K | ﹤0.01% | 2097 |
|
|
2020
Q4 | $1.11M | Sell |
6,658
-56
| -0.8% | -$9.26K | ﹤0.01% | 1768 |
|
|
2020
Q3 | $1.04M | Buy |
6,714
+268
| +4% | +$38.5K | ﹤0.01% | 1603 |
|
|
2020
Q2 | $953K | Sell |
6,446
-335
| -5% | -$46K | ﹤0.01% | 1589 |
|
|
2020
Q1 | $762K | Buy |
6,781
+69
| +1% | +$8.96K | ﹤0.01% | 1601 |
|
|
2019
Q4 | $933K | Buy |
6,712
+2,509
| +60% | +$279K | ﹤0.01% | 1882 |
|
|
2019
Q3 | $407K | Buy |
4,203
+1,616
| +62% | +$180K | ﹤0.01% | 2275 |
|
|
2019
Q2 | $295K | Sell |
2,587
-147
| -5% | -$17.6K | ﹤0.01% | 2510 |
|
|
2019
Q1 | $323K | Buy |
+2,734
| New | +$239K | ﹤0.01% | 2314 |
|
Other funds holding ASND
RCM
ACA